Phase 2 Neuroendocrine Tumors Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

Neuroendocrine TumorsPancreatic Neuroendocrine TumorGastrointestinal Neuroendocrine Tumor+2 more

Aadi Bioscience, Inc.21 enrolled4 locationsNCT05997056

Recruiting

Phase 2

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors

Neuroendocrine TumorsProgressionNeuroendocrine Tumor of Pancreas+4 more

AC Camargo Cancer Center100 enrolled2 locationsNCT06472388